RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

This publication has 32 references indexed in Scilit:

• Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention
  Stroke, 2005
• The cardiovascular continuum and renin–angiotensin–aldosterone system blockade
  Journal Of Hypertension, 2005
• Effects of Candesartan on Cardiovascular Outcomes in Japanese Hypertensive Patients
  Hypertension Research, 2005
• Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese Community
  Stroke, 2003
• Cardiovascular prevention and blood pressure reduction
  Journal Of Hypertension, 2003
• World Heart Day 2002
  Circulation, 2002
• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• Demographic Study of First-ever Stroke and Acute Myocardial Infarction in Okinawa, Japan.
  Internal Medicine, 1998
• Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
  Blood Pressure, 1992
• Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.
  Circulation, 1981